Unknown

Dataset Information

0

Disrupting the α7nAChR-NR2A protein complex exerts antidepressant-like effects.


ABSTRACT: Major depressive disorder (MDD) is associated with significant morbidity and mortality. Most antidepressant medications target the serotonin and norepinephrine transporters, but a significant minority of patients do not respond to treatment and novel therapeutic targets are needed. We previously identified a protein complex composed of the α7 nicotinic acetylcholine receptor (nAChR) and NMDA glutamate receptors (NMDARs), through which α7nAChR upregulates NMDAR function. Disruption of the α7nAChR-NMDAR complex with an interfering peptide blocked α7nAChR-mediated upregulation of NMDAR function and cue-induced reinstatement of nicotine seeking in rat models of relapse. Here we report that disrupting the α7nAChR-NMDAR complex with the interfering peptide also has antidepressant-like effects in the forced swim test (FST), a common rat behaviour screening test for antidepressant effects. Furthermore, the interfering peptide significantly increases extracellular signal-regulated kinase (ERK) activity in the animals subjected to the FST. Our results provide a novel potential therapeutic target for the development of new antidepressant medications.

SUBMITTER: Jiang A 

PROVIDER: S-EPMC8256601 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8170916 | biostudies-literature
| S-EPMC5822462 | biostudies-literature
| S-EPMC6754737 | biostudies-literature
| S-EPMC6337550 | biostudies-literature
| S-EPMC8027594 | biostudies-literature
| S-EPMC6532146 | biostudies-literature
| S-EPMC8686162 | biostudies-literature
| S-EPMC8883047 | biostudies-literature
| S-EPMC5737563 | biostudies-literature
| S-EPMC4256373 | biostudies-literature